Search research articles
Contact Us
Filters
Showing results (361-370 of 706) with videos related to
Page
of 71
Sort By:
American Heart Journal
|
April 1, 2009
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James, Axel Akerblom, Christopher P Cannon, et al.
American Heart Journal
|
July 29, 2014
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population
Michael A Blazing, Robert P Giugliano, Christopher P Cannon, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
You-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Circulation
|
December 22, 2017
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Robert P Giugliano, Christopher P Cannon, Michael A Blazing, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
Eliot A Brinton, Uma Kher, Sukrut Shah, et al.
Clinical Cardiology
|
September 20, 2022
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)
Aleesha Shaik, Mikhail Kosiborod, James A de Lemos, et al.
Journal of the American Heart Association
|
October 17, 2022
Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS
Jennifer A Rymer, Lisa A Kaltenbach, Eric D Peterson, et al.
JAMA Cardiology
|
October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT
Siddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
Thrombosis and Haemostasis
|
January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology
Jacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Page
of 71
Search research articles
Search
Showing results (361-370 of 706) with videos related to
Sort By:
Page
of 71
American Heart Journal
|
April 1, 2009
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James, Axel Akerblom, Christopher P Cannon, et al.
American Heart Journal
|
July 29, 2014
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: final baseline characteristics of the IMPROVE-IT study population
Michael A Blazing, Robert P Giugliano, Christopher P Cannon, et al.
Diabetes, Obesity & Metabolism
|
October 25, 2017
High-sensitivity C-reactive protein, low-density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
You-Cheol Hwang, David A Morrow, Christopher P Cannon, et al.
Circulation
|
December 22, 2017
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
Robert P Giugliano, Christopher P Cannon, Michael A Blazing, et al.
Journal of Clinical Lipidology
|
February 12, 2015
Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial
Eliot A Brinton, Uma Kher, Sukrut Shah, et al.
Clinical Cardiology
|
September 20, 2022
Use of lipid-lowering therapies in patients with chronic kidney disease and atherosclerotic cardiovascular disease: 2-year results from Getting to an imprOved Understanding of Low-Density lipoprotein cholesterol and dyslipidemia management (GOULD)
Aleesha Shaik, Mikhail Kosiborod, James A de Lemos, et al.
Journal of the American Heart Association
|
October 17, 2022
Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out-Of-Pocket Expenses? Insights From ARTEMIS
Jennifer A Rymer, Lisa A Kaltenbach, Eric D Peterson, et al.
JAMA Cardiology
|
October 19, 2022
Association of Serial High-Sensitivity Cardiac Troponin T With Subsequent Cardiovascular Events in Patients Stabilized After Acute Coronary Syndrome: A Secondary Analysis From IMPROVE-IT
Siddharth M Patel, Arman Qamar, Robert P Giugliano, et al.
Thrombosis and Haemostasis
|
January 17, 2003
Acute thrombocytopenia in patients treated with the oral glycoprotein IIb/IIIa inhibitors xemilofiban and orbofiban: evidence for an immune etiology
Jacqueline A Brassard, Brian R Curtis, Richard A Cooper, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 18, 2018
Kidney Biomarkers and Decline in eGFR in Patients with Type 2 Diabetes
Katherine G Garlo, William B White, George L Bakris, et al.
Page
of 71